User profiles for Riitta Lassila

Riitta Lassila

Professor of Coagulation Medicine, University of Helsinki
Verified email at kolumbus.fi
Cited by 11706

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

…, S Husted, J Lopez-Sendon, R Lassila… - European heart …, 2011 - academic.oup.com
Aims More intense platelet-directed therapy for acute coronary syndrome (ACS) may increase
bleeding risk. The aim of the current analysis was to determine the rate, clinical impact, …

Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation

…, P Salven, H Mikkola, R Lassila… - Thrombosis and …, 1998 - thieme-connect.com
VEGF-C is a recently characterised endothelial growth factor structurally related to vascular
endothelial growth factor (VEGF). We studied the expression of VEGF-C and VEGF in the …

European principles of haemophilia care

…, J Astermark, K Fischer, A Gringeri, R Lassila… - …, 2008 - Wiley Online Library
As the management of haemophilia is complex, it is essential that those with the disorder
should have ready access to a range of services provided by a multidisciplinary team of …

[HTML][HTML] Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors

…, P Cortesi, H Jo, K Kavakli, R Lassila… - … England Journal of …, 2011 - Mass Medical Soc
Background Patients with severe hemophilia A and factor VIII inhibitors are at increased risk
for serious bleeding complications and progression to end-stage joint disease. Effective …

Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity

…, S Vehkavaara, M Syrjälä, R Lassila - … , and vascular biology, 2002 - Am Heart Assoc
Insulin resistance is associated with an increased risk of atherothrombotic vascular disease,
but the mechanisms are poorly understood. We determined how insulin in vivo regulates …

Platelet-derived microparticles associate with fibrin during thrombosis

P Siljander, O Carpen, R Lassila - 1996 - ashpublications.org
Platelet-derived microparticles (MP) are reported to express both pro- and anticoagulant
activities. Nevertheless, their functional significance has remained unresolved. The present …

Obesity‐related derangements of coagulation and fibrinolysis: a study of obesity‐discordant monozygotic twin pairs

…, H Yki‐Järvinen, A Silveira, A Hamsten, R Lassila… - …, 2012 - Wiley Online Library
Coagulation and fibrinolytic activities are under strong genetic control. We studied the effects
of acquired obesity, independent of genetic factors on coagulation and fibrinolysis activities …

No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial

…, K Poussa, S Ilveskero, J Hernesniemi, R Lassila - Journal of …, 2003 - thejns.org
Object. From the moment an intracranial aneurysm ruptures, cerebral blood flow is impaired,
and this impairment mainly determines the outcome in patients who survive after the initial …

Increased coagulation factor VIII, IX, XI and XII activities in non‐alcoholic fatty liver disease

…, N Lundbom, A Rissanen, R Lassila… - Liver …, 2011 - Wiley Online Library
Background and aims: Obesity and the metabolic syndrome are established risk factors of
venous thromboembolism. As most coagulation factors are produced exclusively by the liver …

Polymorphisms of COX-1 and GP VI associate with the antiplatelet effect of aspirin in coronary artery disease patients

…, E Kankuri, PJ Karhunen, R Lassila - Thrombosis and …, 2006 - thieme-connect.com
The antiplatelet effect of aspirin varies individually. This study evaluated whether the
antiplatelet effect of aspirin associates with polymorphisms in the genes coding for cyclo-oxygenase…